Advances in Lipid, Polymeric, and Albumin-Based Drug Delivery Systems
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 23
Special Issue Editors
Interests: intranasal dosage form; nose-to-brain delivery; nose-to-blood delivery; polymeric micelle; quality-by-design-based formulation strategies; nanomedicine
Special Issues, Collections and Topics in MDPI journals
Interests: nose-to-brain delivery; nanomedicine; albumin nanoparticles; polymeric micelles; freeze-drying
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Innovations in nanomedicine represent a significant part of contemporary research and development in the pharmaceutical industry and academic settings. As technology has advanced, novel carrier systems with unique properties have emerged, enhancing the physicochemical characteristics of active substances and leading to improved bioavailability and targeted drug delivery. Lipid, polymeric, and albumin-based drug delivery systems have distinct features, requiring careful planning and experimental design to ensure their quality, safety, and efficacy. Designing strategies to overcome challenges posed by various biological barriers is a particularly exciting area in nanoparticle development. Targeted or controlled delivery to tumor sites across the blood–brain barrier also promises improved therapeutic efficacy for numerous diseases, which may currently be limited by inadequate technology.
This Special Issue aims to compile novel investigations of nanoparticle development in the realms of lipid, polymeric, or albumin-based nanoparticles. Review and original research articles are both welcome in this Special Issue, as well as articles from the regulatory perspective of these novel nanocarriers.
Dr. Bence Sipos
Dr. Katona Gábor
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanoparticle
- albumin nanoparticle
- human serum albumin
- polymeric nanoparticle
- polymeric micelle
- PLGA nanoparticle
- lipid nanoparticle
- liposome
- nanomedicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
